Skip to main content
Clinical Trials/NCT06267352
NCT06267352
Not yet recruiting
Not Applicable

Epidemiology and Genomic Surveillance of Methicillin-sensitive Staphylococcus Aureus in ICU Neonatology : Rectal and Nasal Screening, Cross Transmission and Decolonisation

University Hospital, Caen0 sites120 target enrollmentMarch 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
the Aim of This Study is to Describe Genomic Epidemiology of MSSA in Neonatal ICU
Sponsor
University Hospital, Caen
Enrollment
120
Primary Endpoint
frequency of MSSA cross transmission as assessed by WGS
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

Newborns hospitalized in Neonatology are particularly vulnerable to infections, in particular healthcare associated infection (HAI). Staphylococcus aureus represents the 2nd microorganism responsible for sepsis, this infection is particularly serious and like any HAI, it increases the length of hospitalization of newborns and neonatal morbidity.

In September 2020, the CDC published recommendations for the prevention and control of Staphylococcus aureus infections in neonatal intensive care unit/ICU. They specify the indications for implementing a MSSA surveillance strategy as well as the screening and management methods.

Despite the absence of a defined strategy at the national level, our establishment chose to initiate management measures several years ago following serious infections and MSSA epidemics in neonatal intensive care unit/ICU.

With the aim of improving the efficiency of care and evaluating the strategy chosen at the establishment, it is necessary to describing

  • the epidemiology of MSSA carriage and infections
  • cross-transmission of MSSA strains between patients
  • the success rate of decolonization
  • the sensitivity of detection of digestive carriage by stool swabbing in order to limit the number of samples from newborns.
Registry
clinicaltrials.gov
Start Date
March 2024
End Date
June 2026
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • newborns hospitalized in neonatal ICU
  • MSSA carrier

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

frequency of MSSA cross transmission as assessed by WGS

Time Frame: Month 24

Number of patients with acquired MSSA / total number of MSSA carriers

Similar Trials